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http://dx.doi.org/10.1016/j.pedneo.2Malignant triton tumor (MTT) is a highly aggressive malignant neoplasm, classified as a variant
of malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation. MTT is
rarely reported in children, and its true prevalence may be underestimated. We herein report
such a case in an 8-year-old boy who presented with a mass over the trapezius muscle. He was
previously diagnosed with neurofibromatosis in the same area. Four years later, a follow-up
magnetic resonance imaging revealed an intradural tumor recurrence at the level of C1eC7.
An immunohistochemical test result was positive for S-100 protein and desmin, which con-
firmed the diagnosis. The patient outcome was fatal despite multimodal therapy. The possibi-
lity of this rare but devastating tumor must always be considered when patients present with
new compressive spinal symptoms.
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Malignant triton tumor 591. Introduction
Malignant peripheral nerve sheath tumor (MPNST) accounts
for approximately 5e10% of all soft-tissue sarcomas. The
subgroup of tumors in which malignant Schwann cells
coexist with malignant rhabdomyoblasts is termed as
malignant triton tumor (MTT).1 MTT is generally seen in the
head, neck, extremities, and trunk.2 Although an interest-
ing tumor, only limited reports on MTT are available in the
neuro-oncology literature. It can occur in sporadic form in
the setting of neurofibromatosis type 1 (NF-1).Figure 1 (A) Coronal T2-weighted image with fat saturation demo
plexiform neurofibromatosis. (B) Pictomicrograph showing spindle c
matrix [hematoxylin and eosin (H&E stain; 400)]. (C) Coronal turbo
C1eC7 levels, with cord edema extending to the T2 level (arrows).
by hyperchromatic pleomorphic nuclei and prominent nucleoli (H
immunohistochemical positivity for S-100 protein in both elongate
tochemical staining revealing marked cytoplasmic positivity for de2. Case report
An 8-year-old boy presented with a progressively enlarging
mass in his right trapezius muscle for 6 months. Results of
magnetic resonance imaging (MRI) revealed an intra-
medullary tumor from levels C1eC7 along the continuity of
the right upper brachial plexus. Four years before, he was
operated for a plexiform neuroma entangled in the right
brachial plexus, which was dexterously performed by the
cooperation of a neurosurgeon and a plastic surgeon. Upon
further questioning, he elicited a past history of NF; thenstrates a characteristic “bag of worms” appearance (arrow) of
ells with wavy nuclei and cell bodies arranged in a loose myxoid
spin-echo T2-weighted image shows an intradural tumor at the
(D) Pictomicrograph showing hypercellular areas characterized
&E stain; 400). (E) Pictomicrograph of the tumor showing
d and rounded rhabdomyoblastic cells (400). (F) Immunohis-
smin in the areas of rhabdomyoblastic differentiation (400).
60 T.-H. Jaing et alpatient initially presented with a painful nodule measuring
1.5 cm in diameter embedded in the right trapezius muscle.
The strengths of the deltoid, rotator cuff, and biceps were
grade 0e1, and right hand grasp was grade 3. Electro-
myography and nerve conduction velocity indicated lesions
involving the upper and middle trunk of the brachial plexus.
In the father’s family, there were two cases of lower
extremity tumors, which raised the suspicion of a neuro-
fibroma. An initial MRI demonstrated a plexiform morphol-
ogy (bag of worms) of the right brachial plexus, with an
intradural extramedullary mass involving the C4eC6 ver-
tebrae (Figure 1A). A microscopic examination was per-
formed, which showed loose, spindle-shaped cells with
wavy nuclei containing variable amounts of collagen fibers
and myxoid matrix (Figure 1B).
A follow-up MRI 4 years after the surgery showed an
intradural tumor at the C1eC7 levels, with cord edema
extending to the T2 level (Figure 1C). The plexiform neu-
rofibroma of the left shoulder had decreased in size on
follow-up MR images. A laminectomy of C2eC3 and C6eC7
was subsequently performed. The tumor had a smooth
surface and was grayish in color, with exophytic compo-
nents extending ventrally. Multiple sections of the tumor
was studied, which revealed hypercellular areas charac-
terized by hyperchromatic pleomorphic nuclei and prom-
inent nucleoli (Figure 1D). Typical rhabdomyoblasts showed
scattered strap cells with ample eosinophilic cytoplasm
with and without cross striation. Results of immunohis-
tochemical studies were positive for S-100 protein and
desmin (Figure 1E and F). Neoplastic cells with high Ki-67
index (15%) were phenotypically identified by the coex-
pression of vimentin and smooth muscle actin.
The patient was subjected to local radiotherapy and he
received a radiation dose of 50 Gy in 5 weeks followed by
multiagent chemotherapy, which involved a combination of
etoposide (60 mg/m2) and platinum (20 mg/m2) adminis-
tered intravenously everyday for 5 consecutive days every 4
weeks for up to six cycles after the histological con-
firmation of MTT. Nineteen months after the histological
diagnosis of MTT, the patient developed a communicating
hydrocephalus secondary to tumor progression and then
died of subarachnoid hemorrhage. No autopsy was con-
ducted to conclude the cause of death.3. Discussion
MTT has a dismal prognosis owing to its aggressive biological
behavior. There are two types of tumors in the category of
MTT. Those with NF-1 constituted over 70% in one review
involving 36 cases as well as displaying a marked male
predominance, young age, and common presentation in the
head and neck. By contrast, those without NF-1 were of an
older age, showed female predominance, and the tumors
were frequently located on the trunk.3
MTT refers to MPNSTs with rhabdomyoblastic differ-
entiation.1,4 In our case, the tumor developed in the setting
of NF-1. When associated with NF-1, MPNSTs tend to pres-
ent at a younger age than the sporadic counterpart.5 The
estimated incidence rate of MPNST in patients with NF-1 is
2e5%, as compared with 0.001% in the general population.6
The most common anatomical sites include proximalportions of upper and lower extremities, the trunk arising
from the sciatic nerve, the brachial plexuses, and the sacral
plexuses. However, NF-1 is associated with 57% of patients
with an MTT.7 MTTs behave more aggressively than usual
MPNSTs, with estimated survival rates of 2 years (15%) and 5
years (11%).
S-100 protein is immunohistochemically positive in
50e90% of MPNSTs. In addition, desmin, myo-D1, and myo-
genin are immunostains positive for rhabdomyoblasts.8
Moreover, results of immunohistochemical studies showing
positive staining with S-100 protein excludes the differential
diagnosis of rhabdomyosarcoma. Therefore, prudent use of
immunohistochemistry is crucial in making a definitive
diagnosis of MTT. Furthermore, cervical tritons are rare,with
only two previous reports,2,7 which made the case more
interesting. MTT with NF-1 showed marked male predom-
inance with more predilections for younger age groups.9
It is extraordinarily difficult to speculate on treatment
guidelines when dealing with a rare disease. Surgery with
adequate margins constitutes the treatment mainstay with
adjuvant chemotherapy and/or radiotherapy in individual
cases.10 Because MTTs are so rare, no large trials have been
performed to judge the appropriateness of adjuvant
therapy.11e14
MTT is a rare diagnosis but is important to consider in
patients who present with new compressive spinal symp-
toms, particularly in children with plexiform neuro-
fibromas. The authors speculate potential roles for radical
surgery and comprehensive multidisciplinary management
for treating MTT.Acknowledgments
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